Inovio Pharmaceuticals (INO) has emerged as the top candidate for a potential short squeeze, according to recent market data. As of November 9, 2026, the stock carries a significant short interest of 22.2% of its float. The high squeeze score of 92.8, combined with a borrow fee of 22.1%, indicates that short sellers are facing increasing pressure. With a days-to-cover ratio of 0.8, any sudden upward price movement could force a rapid covering cycle. Investors should monitor the borrow fee closely, as the current cost to borrow is elevated, reflecting the difficulty in sourcing shares for short positions.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.